Correlation Between Sonoma Pharmaceuticals and Akanda Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sonoma Pharmaceuticals and Akanda Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonoma Pharmaceuticals and Akanda Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonoma Pharmaceuticals and Akanda Corp, you can compare the effects of market volatilities on Sonoma Pharmaceuticals and Akanda Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonoma Pharmaceuticals with a short position of Akanda Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonoma Pharmaceuticals and Akanda Corp.

Diversification Opportunities for Sonoma Pharmaceuticals and Akanda Corp

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Sonoma and Akanda is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Sonoma Pharmaceuticals and Akanda Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akanda Corp and Sonoma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonoma Pharmaceuticals are associated (or correlated) with Akanda Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akanda Corp has no effect on the direction of Sonoma Pharmaceuticals i.e., Sonoma Pharmaceuticals and Akanda Corp go up and down completely randomly.

Pair Corralation between Sonoma Pharmaceuticals and Akanda Corp

Given the investment horizon of 90 days Sonoma Pharmaceuticals is expected to generate 1.99 times more return on investment than Akanda Corp. However, Sonoma Pharmaceuticals is 1.99 times more volatile than Akanda Corp. It trades about 0.02 of its potential returns per unit of risk. Akanda Corp is currently generating about -0.22 per unit of risk. If you would invest  406.00  in Sonoma Pharmaceuticals on August 26, 2024 and sell it today you would lose (121.00) from holding Sonoma Pharmaceuticals or give up 29.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Sonoma Pharmaceuticals  vs.  Akanda Corp

 Performance 
       Timeline  
Sonoma Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sonoma Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Akanda Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Akanda Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Sonoma Pharmaceuticals and Akanda Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sonoma Pharmaceuticals and Akanda Corp

The main advantage of trading using opposite Sonoma Pharmaceuticals and Akanda Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonoma Pharmaceuticals position performs unexpectedly, Akanda Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akanda Corp will offset losses from the drop in Akanda Corp's long position.
The idea behind Sonoma Pharmaceuticals and Akanda Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine